Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Pacific Biosciences of California Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 06:20PM GMT
Release Date Price: $35.22 (+15.21%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right. Good afternoon. This is Doug Schenkel from the Cowen Life Science and Diagnostic Tools team. It is my pleasure to welcome Christian Henry to the Cowen conference for the first time as CEO and President of Pacific Biosciences. It's also great to have Susan Kim with us, the company's CFO. So thanks, guys, for taking the time to do this with us today.

I think what we're going to do format-wise is -- and just Susan and Christian tell me if I'm messing this up already, but I'll hand over to you guys. We'll go through a brief presentation, and then we'll just pivot to Q&A after.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Yes, that's right. We'll just give a brief overview, and then we'll have plenty of time for questions.

Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Okay. That's fantastic. Well, thanks, guys.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot